tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
BPTH Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsBPTH Upcoming Earnings Report: What to Expect?
3M ago
Bio-Path Holdings’ BP1001-A Study: A New Hope for Solid Tumor Treatment
Premium
Company Announcements
Bio-Path Holdings’ BP1001-A Study: A New Hope for Solid Tumor Treatment
4M ago
Bio-Path Holdings Advances AML Treatment with BP1001 Clinical Trial
Premium
Company Announcements
Bio-Path Holdings Advances AML Treatment with BP1001 Clinical Trial
4M ago
Bio-Path price target lowered to $2 from $9 at Roth Capital
PremiumThe FlyBio-Path price target lowered to $2 from $9 at Roth Capital
9M ago
Bio-Path provides highlights from clinical, operational update
Premium
The Fly
Bio-Path provides highlights from clinical, operational update
9M ago
Is BPTH a Buy, Before Earnings?
Premium
Pre-Earnings
Is BPTH a Buy, Before Earnings?
9M ago
Bio-Path Holdings Reports Promising Pre-Clinical Results
PremiumCompany AnnouncementsBio-Path Holdings Reports Promising Pre-Clinical Results
11M ago
Bio-Path reports results from preclinical studies of BP1001-A
Premium
The Fly
Bio-Path reports results from preclinical studies of BP1001-A
11M ago
BPTH Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
BPTH Upcoming Earnings Report: What to Expect?
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100